Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,443 | -22,641 | -10,340 | -47,911 | -36,496 |
| Depreciation Amortization | 113 | 75 | 37 | 147 | 109 |
| Accounts payable and accrued liabilities | -721 | -439 | -1,993 | 1,605 | -194 |
| Other Working Capital | -3,217 | -3,048 | -4,099 | 6,827 | 5,818 |
| Other Operating Activity | 3,810 | 2,475 | 2,918 | 1,076 | 2,057 |
| Operating Cash Flow | $-34,458 | $-23,578 | $-13,477 | $-38,256 | $-28,706 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | N/A | N/A | -35 | -28 |
| Purchase Of Investment | -116,266 | -44,656 | -27,546 | -98,463 | -53,271 |
| Sale Of Investment | 52,779 | 32,095 | 17,595 | 76,970 | 55,643 |
| Investing Cash Flow | $-63,499 | $-12,561 | $-9,951 | $-21,528 | $2,344 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -11 | -11 | -11 | -126 | -95 |
| Common Stock Issued | 120,824 | 119,701 | 8,938 | 47,464 | 415 |
| Other Financing Activity | -84 | -590 | -222 | 14,146 | 9,697 |
| Financing Cash Flow | $120,729 | $119,100 | $8,705 | $61,484 | $10,017 |
| Beginning Cash Position | 34,097 | 34,097 | 34,097 | 32,397 | 32,397 |
| End Cash Position | 56,869 | 117,058 | 19,374 | 34,097 | 16,052 |
| Net Cash Flow | $22,772 | $82,961 | $-14,723 | $1,700 | $-16,345 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,458 | -23,578 | -13,477 | -38,256 | -28,706 |
| Capital Expenditure | -12 | N/A | N/A | -35 | -28 |
| Free Cash Flow | -34,470 | -23,578 | -13,477 | -38,291 | -28,734 |